---
document_datetime: 2025-01-15 09:12:54
document_pages: 5
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/kesimpta-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: kesimpta-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 3.6137132
conversion_datetime: 2025-12-25 08:12:28.966789
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Kesimpta

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                             | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0024               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                  | 10/01/2025                          | n/a                                         |                                  |           |
| II/0022              | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 12/12/2024                          |                                             | SmPC, Labelling and PL           |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IAIN/0026/G         | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing A.7 - Administrative change - Deletion of manufacturing sites   | 03/12/2024   |            | Annex II and PL   |                                                                                                                                            |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10927 /202309 | Periodic Safety Update EU Single assessment - ofatumumab                                                                                                                                                                                                                                                                                                  | 25/04/2024   | 20/06/2024 | SmPC and PL       | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10927/202309. |
| IA/0021             | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                             | 18/06/2024   | n/a        |                   |                                                                                                                                            |
| N/0019              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                          | 18/03/2024   | 20/06/2024 | PL                |                                                                                                                                            |
| IAIN/0018           | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                        | 28/02/2024   | n/a        |                   |                                                                                                                                            |
| IB/0017/G           | This was an application for a group of variations. B.I.b.2.z - Change in test procedure for AS or starting material/reagent/intermediate - Other variation B.I.b.2.z - Change in test procedure for AS or                                                                                                                                                 | 22/02/2024   | n/a        |                   |                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|                     | variation B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)   |            |            |             |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------------------------------|
| II/0013/G           | This was an application for a group of variations. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data A.6 - Administrative change - Change in ATC                                                                                                                            | 18/01/2024 | 20/06/2024 | SmPC and PL |                                   |
| IAIN/0016           | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                         | 04/01/2024 | n/a        |             |                                   |
| IB/0014             | B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation                                                                                                                                                                                                                                                                                                                                                  | 21/11/2023 | n/a        |             |                                   |
| PSUSA/10927 /202303 | Periodic Safety Update EU Single assessment - ofatumumab                                                                                                                                                                                                                                                                                                                                                                                   | 26/10/2023 | n/a        |             | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| PSUSA/10927 /202209   | Periodic Safety Update EU Single assessment - ofatumumab                                                                                                                                                                               | 14/04/2023   | n/a        |                 | PRAC Recommendation - maintenance   |
|-----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|-------------------------------------|
| IB/0010               | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                          | 15/03/2023   | n/a        |                 |                                     |
| II/0006               | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                      | 09/02/2023   | 22/09/2023 | SmPC            |                                     |
| IAIN/0011             | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 13/01/2023   | 22/09/2023 | Annex II and PL |                                     |
| PSUSA/10927 /202203   | Periodic Safety Update EU Single assessment - ofatumumab                                                                                                                                                                               | 27/10/2022   | n/a        |                 | PRAC Recommendation - maintenance   |
| IB/0008               | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                       | 21/10/2022   | n/a        |                 |                                     |
| II/0007               | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                      | 20/10/2022   | 22/09/2023 | SmPC            |                                     |
| PSUSA/10927 /202109   | Periodic Safety Update EU Single assessment - ofatumumab                                                                                                                                                                               | 05/05/2022   | n/a        |                 | PRAC Recommendation - maintenance   |

<div style=\"page-break-after: always\"></div>

| IB/0004/G   | This was an application for a group of variations. B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol B.II.f.1.d - Stability of FP - Change in storage conditions of the finished product or the diluted/reconstituted product   | 22/03/2022   | 24/05/2022   | SmPC and PL   |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------|
| IA/0002     | B.I.c.2.c - Change in the specification parameters and/or limits of the immediate packaging of the AS - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                                                            | 02/11/2021   | n/a          |               |
| IA/0001     | A.6 - Administrative change - Change in ATC Code/ATC Vet Code                                                                                                                                                                                                                                                                                                     | 12/05/2021   | 24/05/2022   | SmPC          |